Harris Todd's Form 4 filing
Tyra Biosciences, Inc. (TYRA) · filed Oct 17, 2024
- Accession no.
- 0000950170-24-115432
- Filed
- Oct 17, 2024
- Trade date
- Oct 15-17, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions. Open-market sales total $1.51M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Harris ToddCIK 0001711463 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2024 | Common Stock | SSaleDisposed | −10,035 | $24.31F2 | −$243,950.85 | 1,467,338 | Direct | |
| Oct 16, 2024 | Common Stock | SSaleDisposed | −4,900 | $25.22F3 | −$123,578 | 1,462,438 | Direct | |
| Oct 16, 2024 | Common Stock | SSaleDisposed | −24,475 | $26.23F4 | −$641,979.25 | 1,437,963 | Direct | |
| Oct 16, 2024 | Common Stock | SSaleDisposed | −3,922 | $26.98F5 | −$105,815.56 | 1,434,041 | Direct | |
| Oct 17, 2024 | Common Stock | SSaleDisposed | −15,194 | $25.84F6 | −$392,612.96 | 1,418,847 | Direct | |
| Oct 17, 2024 | Common Stock | SSaleDisposed | −200 | $26.37 | −$5,274 | 1,418,647 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $24.00 to $24.8667. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.
- F3
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $24.72 to $25.59. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.
- F4
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $25.78 to $26.78. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.
- F5
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $26.79 to $27.08. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.
- F6
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $25.30 to $26.16. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.